IPA - ImmunoPrecise Antibodies Ltd.

0.4042
0.044   10.960%

Share volume: 703,283
Last Updated: 04-07-2025
Pharmaceutical Products/Pharmaceutical Preparations: 0.00%

PREVIOUS CLOSE
CHG
CHG%
$0.36
0.04
0.12%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
8%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 20%
Performance
5 Days
18.88%
1 Month
7.41%
3 Months
-25.70%
6 Months
-35.70%
1 Year
-71.54%
2 Year
-86.11%
Key data
Stock price
$0.40
P/E Ratio 
0.00
DAY RANGE
$0.33 - $0.41
EPS 
N/A
52 WEEK RANGE
$0.27 - $1.43
52 WEEK CHANGE
-$70.71
MARKET CAP 
20.613 M
YIELD 
N/A
SHARES OUTSTANDING 
27.302 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-28-2025
BETA 
2.24
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$462,408
AVERAGE 30 VOLUME 
$2,182,160
Company detail
CEO: Jennifer L. Bath
Region: US
Website: ipatherapeutics.com
Employees: 80
IPO year: 2008
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

ImmunoPrecise Antibodies Ltd. engages in antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products.

Recent news
loading